75 related articles for article (PubMed ID: 15077568)
21. Novel insights in chronic lymphocytic leukemia: are we getting closer to understanding the pathogenesis of the disease?
Caligaris-Cappio F; Ghia P
J Clin Oncol; 2008 Sep; 26(27):4497-503. PubMed ID: 18662968
[TBL] [Abstract][Full Text] [Related]
22. Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities.
Mittal AK; Hegde GV; Aoun P; Bociek RG; Dave BJ; Joshi AD; Sanger WG; Weisenburger DD; Joshi SS
Int J Mol Med; 2007 Oct; 20(4):461-9. PubMed ID: 17786276
[TBL] [Abstract][Full Text] [Related]
23. Flavopiridol-induced iNOS downregulation during apoptosis of chronic lymphocytic leukemia cells is caspase-dependent.
Billard C; Menasria F; Quiney C; Faussat AM; Kolb JP
Leuk Res; 2008 May; 32(5):755-60. PubMed ID: 17981326
[TBL] [Abstract][Full Text] [Related]
24. In vivo dynamics of stable chronic lymphocytic leukemia inversely correlate with somatic hypermutation levels and suggest no major leukemic turnover in bone marrow.
van Gent R; Kater AP; Otto SA; Jaspers A; Borghans JA; Vrisekoop N; Ackermans MA; Ruiter AF; Wittebol S; Eldering E; van Oers MH; Tesselaar K; Kersten MJ; Miedema F
Cancer Res; 2008 Dec; 68(24):10137-44. PubMed ID: 19074880
[TBL] [Abstract][Full Text] [Related]
25. Anti-apoptosis function of TNF-alpha in chronic lymphocytic leukemia: lessons from Crohn's disease and the therapeutic potential of bupropion to lower TNF-alpha.
Kast RE; Altschuler EL
Arch Immunol Ther Exp (Warsz); 2005; 53(2):143-7. PubMed ID: 15928583
[TBL] [Abstract][Full Text] [Related]
26. Genomics of chronic lymphocytic leukemia microRNAs as new players with clinical significance.
Calin GA; Croce CM
Semin Oncol; 2006 Apr; 33(2):167-73. PubMed ID: 16616063
[TBL] [Abstract][Full Text] [Related]
27. Chronic lymphocytic leukemia and hairy-cell leukemia.
Cheson BD
Curr Opin Hematol; 1994 Jul; 1(4):268-77. PubMed ID: 9371293
[TBL] [Abstract][Full Text] [Related]
28. [Chronic lymphocytic leukemia (CLL)].
Ito S; Kuriya S
Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):95-8. PubMed ID: 9851093
[No Abstract] [Full Text] [Related]
29. Molecular biology of chronic lymphocytic leukemia: implications for therapy.
Reed JC
Semin Hematol; 1998 Jul; 35(3 Suppl 3):3-13. PubMed ID: 9685174
[No Abstract] [Full Text] [Related]
30. [Spontaneous remission in chronic lymphatic leukemia].
Frick S; Frick P
Schweiz Med Wochenschr; 1993 Feb; 123(8):328-34. PubMed ID: 8451615
[TBL] [Abstract][Full Text] [Related]
31. CTLA-4 affects expression of key cell cycle regulators of G0/G1 phase in neoplastic lymphocytes from patients with chronic lymphocytic leukaemia.
Ciszak L; Frydecka I; Wolowiec D; Szteblich A; Kosmaczewska A
Clin Exp Med; 2016 Aug; 16(3):317-32. PubMed ID: 26003188
[TBL] [Abstract][Full Text] [Related]
32. [Treatment of patients with chronic lymphocytic leukemia].
Mucsi O
Magy Onkol; 2016 Jun; 60(2):127-36. PubMed ID: 27275639
[TBL] [Abstract][Full Text] [Related]
33. A Personalized Framework for Dynamic Modeling of Disease Trajectories in Chronic Lymphocytic Leukemia.
Savvopoulos S; Misener R; Panoskaltsis N; Pistikopoulos EN; Mantalaris A
IEEE Trans Biomed Eng; 2016 Nov; 63(11):2396-2404. PubMed ID: 26929022
[TBL] [Abstract][Full Text] [Related]
34. The effects of CpG ODN on CLL proliferation, apoptosis or phenotype could have an impact on its clinical utility.
Jahrsdorfer B; Blackwell S; Weiner G
Leukemia; 2007 Nov; 21(11):2354-5; author reply 2355-6. PubMed ID: 17657215
[No Abstract] [Full Text] [Related]
35. [An attempt to clarify the etiopathogenesis of chronic lymphatic B-cell leukemia].
Kiersnowska-Rogowska B; Parfieńczyk A; Rogowski F; Bodzenta-Lukaszyk A; Sawicka-Powierza J
Pol Merkur Lekarski; 1999 Nov; 7(41):234-5. PubMed ID: 10680460
[TBL] [Abstract][Full Text] [Related]
36. Quality of life in chronic lymphocytic leukemia: a neglected issue.
Molica S
Leuk Lymphoma; 2005 Dec; 46(12):1709-14. PubMed ID: 16263572
[TBL] [Abstract][Full Text] [Related]
37. Relationship between Chromosomal Aberrations and Gene Expressions in the p53 Pathway in Chronic Lymphocytic Leukemia.
Öztan G; Aktan M; Palanduz S; İşsever H; Öztürk S; Nikerel E; Uçur A; Bağatir G; Bayrak A; Çefle K
Balkan J Med Genet; 2020 Jun; 23(1):15-24. PubMed ID: 32953405
[TBL] [Abstract][Full Text] [Related]
38. [Apoptosis in chronic lymphocytic leukemia].
Brajusković G; Milić AS; Vukosavić S; Romac S; Cerović S; Knezević-Usaj S; Popović L; Marjanović S; Dimitrijević J
Vojnosanit Pregl; 2002; 59(6 Suppl):47-52. PubMed ID: 12852146
[No Abstract] [Full Text] [Related]
39. Transcriptional activity of repair, apoptosis and cell cycle genes (TP53, MDM2, ATM, BAX, BCL-2, CDKN1A, OGG1, XPC, PADI4, MAPK8, NF-KB1, STAT3, GATA3) in chronically exposed persons with different intensity of apoptosis of peripheral blood lymphocytes.
Nikiforov VS; Blinova EA; Kotikova AI; Akleyev AV
Vavilovskii Zhurnal Genet Selektsii; 2022 Feb; 26(1):50-58. PubMed ID: 35342850
[TBL] [Abstract][Full Text] [Related]
40. Leukemia & lymphoma.
Berrebi A
Leuk Lymphoma; 2001 Jun; 42(1-2):1-3. PubMed ID: 11699196
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
